| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 21,174 | 22,160 | 22,514 | 21,857 | | Cost of Revenue | 5,088 | 5,286 | 5,600 | 5,641 | | | Gross Profit |
-
| 16,874 | 16,914 | 16,216 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,575 | 10,913 | 9,975 | 11,149 | | Non Recurring |
-
|
-
|
-
| 28,969 | | Others | 2,022 | 1,948 | 2,047 | 6,422 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 4,013 | 4,892 | (30,325) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 3,644 | 3,936 | 4,815 | (30,233) | | Interest Expense | 2,350 | 2,538 | 2,665 | 2,923 | | Income Before Tax | 1,294 | 1,398 | 2,150 | (33,156) | | Income Tax Expense | 52 | 83 | 354 | (8,309) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,242 | 1,315 | 1,796 | (24,847) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,242 | 1,315 | 1,796 | (24,847) | | Preferred Stock And Other Adjustments | (451) | (451) | (451) |
-
| | | Net Income Applicable To Common Shares | $791 | $864 | $1,345 | ($24,847) |
|
0.51% Nasdaq 
Income Statement
